HBI
59
4
NEM
44
-2
NAVI
52
-3
HSIC
60
-2
F
54
-6
FLR
56
-2
INTC
40
-4
PM
66
4
PSX
50
3
DNB
82
-2
RIG
55
-6
O
24
2
DHR
41
2
OI
38
-5
UPS
61
-3
TSN
42
3
WMT
79
3
RSG
76
2
GE
72
4
AMGN
31
-16
HBI
59
4
NEM
44
-2
NAVI
52
-3
HSIC
60
-2
F
54
-6
FLR
56
-2
INTC
40
-4
PM
66
4
PSX
50
3
DNB
82
-2
RIG
55
-6
O
24
2
DHR
41
2
OI
38
-5
UPS
61
-3
TSN
42
3
WMT
79
3
RSG
76
2
GE
72
4
AMGN
31
-16
Financhill
Back

Discover Financial Services Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
64

DFS
Discover Financial Services

Last Price:
181.13
Seasonality Move:
3.23%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.74
Seasonality Move:
14.88%
Buy
64
Discover Financial Services (DFS) is a Buy

Is Discover Financial Services a Buy, Sell or Hold?

  • The current Discover Financial Services [DFS] share price is $182.62. The Score for DFS is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • DFS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DFS Stock Price Chart

What is Discover Financial Services's stock price today?

  • The Discover Financial Services share price today is $182.62
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DFS is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

DFS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8 Buy
Relative Strength Index (14 RSI): 68.6 Buy
Chaikin Money Flow: 475514 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (152.17 - 179.87) Buy
Bollinger Bands (100): (128.25 - 159.47) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

DFS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 176.76 Buy
20-day SMA: 170.48 Buy
50-day SMA: 153.91 Buy
200-day SMA: 133.81 Buy
8-day EMA: 177.77 Buy
20-day EMA: 170.67 Buy
50-day EMA: 158.04 Buy
200-day EMA: 135.74 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Discover Financial Services Earnings Growth & DFS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and a decrease next year of $1.07 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Discover Financial Services Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):